Cernapex, Inc is an early stage biotechnology company focused on the restoration and maintenance of peroxisomal function.  Our strategy is to partner with leading universities and medical institutes to use the latest metabolic and genetic technologies for the treatment of peroxisomal dysfunction.  Currently, our lead therapeutic research is concentrated on restoration of the key peroxisomal enzymes.

Peroxisomes

The peroxisome is a key organelle of the cell and is involved in the metabolism of very long chain fatty acids as well as detoxification of the cell.  Studies have shown that peroxisomal function may decrease with age, contributing to metabolic disorders and particular cancers.  Severe dysfunction of the peroxisome and peroxisomal enzymes leads to the rare family of metabolic disorders known as peroxisomal disorders.  Our research aim is to elucidate the nature of peroxisomal dysfunction and develop therapies that restore and maintain peroxisomal function throughout life.

Partnering

If you are interested in partnering with Cernapex, please visit our 'contact us' page or send us a description of your interest to the email below.

Cernapex Business Development
partner@cernapex.com